A GENETICALLY ENGINEERED MUTANT OF α1-ANTITRYPSIN PROTECTS CONNECTIVE TISSUE FROM NEUTROPHIL DAMAGE AND MAY BE USEFUL IN LUNG DISEASE
- 1 December 1984
- journal article
- preliminary communications
- Published by Elsevier in The Lancet
- Vol. 324 (8417-8418) , 1426-1428
- https://doi.org/10.1016/s0140-6736(84)91623-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Synthesis in yeast of a functional oxidation-resistant mutant of human α1-antitrypsinNature, 1984
- Molecular medicine: Therapy by instant evolutionNature, 1984
- Degradation of glomerular basement membrane by human neutrophils in vitroBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1984
- Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites.Journal of Clinical Investigation, 1984
- Mutation of Antitrypsin to AntithrombinNew England Journal of Medicine, 1983
- Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia.Journal of Clinical Investigation, 1983
- Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid.Journal of Clinical Investigation, 1983
- Structure and variation of human α1–antitrypsinNature, 1982
- Leukocyte Recruitment to Airways by Cigarette Smoke and Particle Phase in Contrast to Cytotoxicity of VaporScience, 1975
- The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin DeficiencyScandinavian Journal of Clinical and Laboratory Investigation, 1963